Skip to main content
Premium Trial:

Request an Annual Quote

Vitra Bioscience Raises $5.5M in Private Financing

NEW YORK, July 14 (GenomeWeb News) - Vitra Bioscience has raised $5.5 million in a second round of financing, the Mountain View, Calif.-based company said today.


Vitra said it will use the funds to help commercialize its CellCard System and to expand the company's product offerings. Alta Partners led the investment round with participation from Sofinnova Ventures, Mediphase Venture Partners, and Three Arch Partners.


The CellCard System facilitates parallel screening of multiple cell types for lead identification and optimization in drug discovery.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.